AFQ056

Search structure
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Fragile X Syndrome; Syndrome Phase 2 ClinicalTrials
Esophagitis, Peptic; Gastroesophageal Reflux Phase 1 ClinicalTrials
Compulsive Personality Disorder; Obsessive-Compulsive Disorder Phase 2 ClinicalTrials
Dyskinesias; Parkinson Disease Phase 2 ClinicalTrials
Renal Insufficiency Phase 1 ClinicalTrials
Fragile X Syndrome; Syndrome Phase 2/Phase 3 ClinicalTrials
Dyskinesia, Drug-Induced; Dyskinesias; Parkinson Disease Phase 2 ClinicalTrials
Fragile X Syndrome; Syndrome Phase 1 ClinicalTrials
Chorea; Huntington Disease Phase 2 ClinicalTrials
Fragile X Syndrome; Syndrome Phase 2 ClinicalTrials
Fragile X Syndrome; Syndrome Phase 2 ClinicalTrials
Fragile X Syndrome; Syndrome Phase 2 ClinicalTrials
Disease; Dyskinesias; Movement Disorders; Parkinson Disease; Parkinsonian Disorders Phase 2 ClinicalTrials
Disease; Dyskinesias; Movement Disorders; Parkinson Disease; Parkinsonian Disorders Phase 2 ClinicalTrials
Disease; Dyskinesias; Movement Disorders; Parkinson Disease; Parkinsonian Disorders Phase 2 ClinicalTrials
Liver Diseases Phase 1 ClinicalTrials
Dyskinesias; Parkinson Disease Phase 2 ClinicalTrials
Dyskinesias; Parkinson Disease Phase 2 ClinicalTrials
Cocaine-Related Disorders; Disease Phase 2 ClinicalTrials
CONTENTS